Early Trials: Johnson & Johnson COVID Vaccine Prompts Immune Response

Newsy

14 Jan 2021 0 shares 2 views

Early Trials: Johnson & Johnson COVID Vaccine Prompts Immune Response

Early Trials: Johnson & Johnson COVID Vaccine Prompts Immune Response

Newsy

Published 14 Jan 2021

Watch VideoJohnson & Johnson’s one-dose coronavirus vaccine is safe and seems to cause an immune response in both young and elderly volunteers.The vaccine works differently than the two emergency-approved vaccines being shot into arms now.

"It uses a common cold virus called an adenovirus, and it basically splices in the...

You might like

Related news coverage

Study: J&J COVID-19 Vaccine 72% Effective in U.S.

Study: J&J COVID-19 Vaccine 72% Effective in U.S.

Newsy 29 Jan 2021

Watch VideoAnother drugmaker is sharing the data that their COVID vaccine works. In clinical trials of more than 43,000 people,..

Covid-19 Variants And Vaccine Efficacy

Covid-19 Variants And Vaccine Efficacy

Newsy

28 Jan 2021

Merck ends development of two potential COVID-19 vaccines

SeattlePI.com

25 Jan 2021

Coronavirus updates: Research teams discover new variants of US COVID-19; Pope Francis gets Pfizer vaccine
Upworthy 14 Jan 2021
Johnson & Johnson COVID-19 vaccine induces immune response after 1 dose: study
Upworthy 14 Jan 2021

Advertisement

More coverage

Johnson & Johnson coronavirus vaccine generates immune response, few side effects, in early trials

Johnson & Johnson's experimental coronavirus vaccine generated an immune response in nearly all volunteers, with minimal..

Upworthy 13 Jan 2021